W. A. Peters, P. Y. Liu, R. J. Barrett, et al., “Concurrent Chemotherapy and Pelvic Radiation Therapy Compared with Pelvic Radiation Therapy Alone as Adjuvant Therapy after Radical Surgery in High-Risk Early-Stage Cancer of the Cervix,” Journal of Clinical Oncology, Vol. 18, No. 8, 2000, pp. 1606-1613.
 J. M. Kirwan, P. Symonds, J. A. Green, et al., “A SystemAtic Review of Acute and Late Toxicity of Concomitant Chemoradiation for Cervical Cancer,” Radiotherapy and Oncology, Vol. 68, No. 3, 2003, pp. 217-226. doi:10.1016/S0167-8140(03)00197-X
 K. Serkies and J. Jassem, “Concurrent Weekly Cisplatin and Radiotherapy in Routine Management of Cervical Cancer: A Report on Patient Compliance and Acute Toxicity,” International Journal of Radiation Oncology Biology Physics, Vol. 60, No. 3, 2004, pp. 814-821. doi:10.1016/j.ijrobp.2004.04.042
 J. Howell, J. Smeets, et al., “Pharmacokinetics of a Granisetron Transdermal System for the Treatment of Chemotherapy-Induced Nausea and Vomiting,” Journal of Oncology Practice, Vol. 15, No. 4, 2009, pp. 223-231.
 Granisetron Transdermal System (Sancuso-Prostraken), “Package Insert,” 2010. http://health.utah.gov/medicaid/pharmacy/ptcommittee/files/Criteria%20Review%20Documents/Antiemetics%20(Febrary%202010)/Medicaid_granisetron_transderm_020310.pdf
 S. Grunberg, R. A. Clark-Snow and J. Koeller, “Chemotherapy-Induced Nausea and Vomiting: Contemporary Approaches to Optimal Management,” Supportive Care in Cancer, Vol. 18, No. 1, 2010, pp. S1-S10. doi:10.1007/s00520-009-0807-z